On April 1, the Trump administration slashed the organization that supported that research — the Agency for Healthcare ...

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.

In a survey last year by the American Medical Association, 93% of doctors said that insurers’ prior authorization practices ...

More than 3.8 million US lung cancer deaths were averted during 1970-2022 due to tobacco control, researchers say.

The FDA has approved Imfinzi (durvalumab) as neoadjuvant and adjuvant treatment in patients with muscle-invasive bladder cancer.

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

Partial nephrectomy provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC), according to research presented at the 40th ...

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

The federal government is clawing back $11.4 billion in COVID-19 funding, a move that could affect local and state public health efforts across the US.

A top official at the FDA is stepping down, warning that the HHS secretary aims to spread misinformation and lies.

The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.